Accentia Biopharmaceuticals Inc (1310094) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, September 30, 2009

Accentia Biopharmaceuticals Inc

CIK: 1310094

View differences made from one year to another to evaluate Accentia Biopharmaceuticals Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accentia Biopharmaceuticals Inc.


Assess how Accentia Biopharmaceuticals Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accentia Biopharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2010 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Accentia Biopharmaceuticals Inc provided additional information to their SEC Filing as exhibits

CIK: 1310094
Form Type: 10-K Annual Report
Accession Number: 0001193125-10-189742
Submitted to the SEC: Mon Aug 16 2010 11:13:38 AM EST
Accepted by the SEC: Mon Aug 16 2010
Period: Wednesday, September 30, 2009
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink: